Last week, The Lancet had to retract the most highly-touted hydroxychloroquine study to date, which was used as evidence for entire countries to change their stance on the drug.
The study, which was obviously flawed on its face, turned out to be produced by a shell company, with unverified data gathered by non-scientists.